tirzepatide fasting A) The SURPASS Program (SURPASS1–6). TZP, Tirzepatide; FSG, At a glance factsheet: Intermittent

Weight loss during this period is moderate, typically 3% to 5% of body weight

Tirzepatide and other GLP-1 RA drugs may cause severe and potentially fatal side effects

Delayed Gastric Emptying One of cagrilintide's most pronounced effects is slowing the rate of gastric emptying through activation of amylin receptors in the area postrema and vagal afferent pathways [5] : Central Nervous System Signaling: Activation of AMY1 receptors in the area postrema initiates vagal efferent signals that reduce gastric motility and pyloric relaxation [15] Direct Peripheral Effects: AMY3 receptor activation in the stomach and proximal small intestine may contribute to local motor function regulation [16] Metabolic Consequences: Delayed gastric emptying reduces the rate of glucose appearance in the bloodstream, lowering postprandial glucose excursions without increasing insulin demand [5] In Phase 2 trials, cagrilintide demonstrated dose-dependent reductions in gastric emptying rate, with effects sustained over the week-long dosing interval [9]

Youll also get simple dosing/timing guidance and what to look for on labels

State-licensed pharmacies must stop making most compounded semaglutide (copies of Novo Nordisks Wegovy and Ozempic) by April 22, and larger outsourcing pharmacies by May 22, or when district court rules on a pending injuction whichever is first